ÂÜÀòÂÒÂ×

Faraz Ali is the Chief Executive Officer of Tenaya Therapeutics and a member of the Board of Directors for the Alliance for Regenerative Medicine. Previously, Faraz served as Chief Business Officer at REGENXBIO Inc. and held the role of Vice President, Global Commercial Development and External Affairs at bluebird bio. Faraz is also a committee member of the NEWDIGS consortium for the Financing of Cures in the US (FoCUS) project at the Massachusetts Institute of Technology. Faraz possesses an MBA in General Management from Harvard Business School and a BS in Electrical Engineering with a biomedical focus from Stanford University.